Aim: The aim of our study was to describe an effective technique for mastoid cavity obliteration in canal wall down tympanomastoidectomy for chronic otitis media and to review its efficacy in producing a dry, low-maintenance, small mastoid cavity.Material and Method: A retrospective clinical study of 56 consecutive patients undergoing procedures for active chronic otitis media with cholesteatoma has been carried out. All surgical interventions involved partial mastoid obliteration and restoration of the middle ear space by use of cartilage reconstruction of the tympanic membrane. Ossicular reconstruction was achieved with either a partial or total ossicular replacement prosthesis. Results: A completely dry cavity was achieved in 49 of 56 patients (approx. 88%, 95% confidence interval 77–95%). An overall statistically significant improvement in hearing (p < 0.05) was obtained, with the mean pure-tone average air-bone gap decreasing from 33.4 ± 8.2 dB (average ± SD) to 18.3 ± 9.7 dB. There were no residual or recurrent cholesteatomas. Conclusion: Cartilage reconstruction of the tympanic membrane proved to be a useful adjunct in the surgical management of the chronically draining cavity.

1.
Sheehy JL, Brackmann DE: Surgery of chronic otitis media; in English GM (ed): Otolaryngology. Philadelphia, Lippincott, 1994, vol 1, pp 1–87.
2.
Chole RA, Holger H: Sudhoff chronic otitis media, mastoiditis, and petrositis; in Cummings CW, Flint PW, Harker LA (eds): Otolaryngology, Head and Neck Surgery. Philadelphia, Elsevier Mosby, 2010, p 3082.
3.
Kos MI, Cartrillon R, Montandon P, Guyot JP: Anatomic and functional long-term results of canal wall-down mastoidectomy. Ann Otol Rhinol Laryngol 2004;113:872–876.
4.
Mehta RP, Harris JP: Mastoid obliteration. Otolaryngol Clin North Am 2006;39:1129–1142.
5.
Linthicum FH Jr: The fate of mastoid obliteration tissue: a histopathological study. Laryngoscope 2002;112:1777–1778.
6.
Yamamoto E, Iwanaga M, Fukumoto M: Histologic study of homograft cartilage implanted in the middle ear. Otolaryngol Head Neck Surg 1988;98:546–551.
7.
Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. Otolaryngol Head Neck Surg 1995;113:186–187.
8.
Jäntschi L, Bolboacă SD: Exact probabilities and confidence limits for binomial samples: applied to the difference between two proportions. Sci World J 2010;10:865–878.
9.
Mark J, Syms MD, William M, Luxford MD: Management of cholesteatoma: status of the canal wall. Laryngoscope 2003;113:443–448.
10.
Mosher HP: A method of filling the excavated mastoid with a flap from the back of the auricle. Laryngoscope 1911;21:1158–1163.
11.
Lee DH, Jun BC, Jung SH, Song CE: Deep temporal fascial-periosteal flap for canal wall down mastoidectomy. Laryngoscope 2006;116:2229–2231.
12.
Peer LA: Diced cartilage grafts. Arch Otolaryngol Head Neck Surg 1943;38:156–165.
13.
Heermann J, Heermann H, Kopstein E: Fascia and cartilage palisade tympanoplasty. Arch Otolaryngol Head Neck Surg 1970;91:228–241.
14.
Filipo R, Barbara M, Mancini P: Long-term follow-up of rehabilitation of radical cavities; in Tos M, Thomsen J, Peitersen E (eds): Cholesteatoma and Mastoid Surgery. Amsterdam, Kugler & Ghedini, 1989, pp 63–66.
15.
Brask T: Obliteration of the mastoid cavities with crushed homograft cartilage in patients with cholesteatoma; in Tos M, Thomsen J, Peitersen E (eds): Cholesteatoma and Mastoid Surgery. Amsterdam, Kugler & Ghedini, 1989, pp 931–933.
16.
Zahnert T, Huttenbrink KB, Murbe D, Bornitz M: Experimental investigations of the use of cartilage in tympanic membrane reconstruction. Am J Otol 2000;21:322–328.
17.
Dornhoffer J: Surgical modification of the difficult mastoid cavity. Otolaryngol Head Neck Surg 1999;120:361–367.
18.
Choi IJ, Song JJ, Jang JH, Chang SO: A novel meatoplasty method in canal wall down tympanomastoidectomy: a perichondrial posterior fixation technique. Clin Exp Otorhinolaryngol 2009;2:164–168.
19.
Yung M, Tassone P, Moumoulidis I, Vivekanandan S: Surgical management of troublesome mastoid cavities. J Laryngol Otol 2011;125:221–226.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.